Hypogonadotropic Hypogonadism

 

 Buy Article Permissions and Reprints

ABSTRACT

Hypogonadotropic hypogonadism is characterized by failure of gonadal function secondary to deficient gonadotropin secretion, resulting from either a pituitary or hypothalamic defect, and is commonly seen in association with structural lesions or functional defects affecting this region. Although the genetic basis for idiopathic hypogonadotropic hypogonadism is largely unknown, mutations in several genes involved in the hypothalamo-pituitary-gonadal axis development and function have recently been implicated in the pathogenesis of this condition. Genes currently recognized to be involved include KAL-1 (associated with X-linked Kallmann Syndrome), gonadotropin-releasing hormone (GnRH) receptor, gonadotropins, pituitary transcription factors (HESX1, LHX3, and PROP-1), orphan nuclear receptors (DAX-1, associated with X-linked adrenal hypoplasia congenital, and SF-1), and three genes also associated with obesity (leptin, leptin receptor, and prohormone convertase 1 [PC1]). Study of these mutations provides an important contribution in the understanding of the different stages of the reproductive axis development and physiology. Treatment options currently available for puberty induction, maintenance replacement therapy, and fertility induction are considered here. Gametogenesis can be induced with either exogenous gonadotropin or pulsatile GnRH therapy, depending on the etiology.

REFERENCES

• 1 Seeburg P H, Adelman J P. Characterization of cDNA for precursor of human luteinizing hormone releasing hormone.  Nature . 1984;  1311 666-668
  PubMedGoogle Scholar
• 2 Themmen A PN, Huhtaniemi I T. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function.  Endocr Rev . 2000;  21 551-583
  CrossrefPubMedGoogle Scholar
• 3 Terasawa E, Fernandez D L. Neurobiological mechanisms of the onset of puberty in primates.  Endocr Rev . 2001;  22 111-151
  CrossrefPubMedGoogle Scholar
• 4 Seminara S B, Hayes F J, Crowley Jr F W. Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations.  Endocr Rev . 1998;  19 521-539
  CrossrefPubMedGoogle Scholar
• 5 Winter J S, Faiman C, Hobson W C, Prasad A V, Reyes F I. Pituitary-gonadal relations in infancy I: patterns of serum gonadotropin concentrations from birth to four years of age in man and chimpanzee.  J Clin Endocrinol Metab . 1975;  40 545-551
  PubMedGoogle Scholar
• 6 Wu F C, Butler G E, Kelnar C J, Stirling H F, Huhtaniemi I. Patterns of pulsatile luteinizing hormone and follicle-stimulating hormone secretion in prepubertal (midchildhood) boys and girls and patients with idiopathic hypogonadotropic hypogonadism (Kallmann's syndrome): a study using an ultrasensitive time-resolved immunofluorometric assay.  J Clin Endocrinol Metab . 1991;  72 1229-1237
  PubMedGoogle Scholar
• 7 Mitamura R, Yano K, Suzuki N, Ito Y, Makita Y, Okuno A. Diurnal rhythms of luteinizing hormone, follicle-stimulating hormone, and testosterone secretion before the onset of male puberty.  J Clin Endocrinol Metab . 1999;  84 29-37
  CrossrefPubMedGoogle Scholar
• 8 Grumbach M M, Styne D M. Puberty: ontogeny, neuroendocrinology, physiology, and disorders. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. Williams' Textbook of Endocrinology Philadelphia: W.B. Saunders 1998: 1509-1625
  Google Scholar
• 9 MacColl G, Quinton R, Bouloux P M. GnRH neuronal development: insights into hypogonadotrophic hypogonadism.  Trends Endocrinol Metab . 2002;  13 112-118
  PubMedGoogle Scholar
• 10 Quinton R, Duke V M, Robertson A. Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization.  Clin Endocrinol (Oxf) . 2001;  55 163-174
  CrossrefPubMedGoogle Scholar
• 11 Quinton R, Duke V M, de Zoysa A P. The neuroradiology of Kallmann's syndrome: a genotypic and phenotypic analysis.  J Clin Endocrinol Metab . 1996;  81 3010-3017
  CrossrefPubMedGoogle Scholar
• 12 Silveira L FG, MacColl G S, Stewart P, Thomas M, Bouloux P MG. Novel homozygous splice site GnRH receptor mutation associated with severe familial hypogonadotropic hypogonadism. Proceedings of the 83nd annual meeting of The Endocrine Society, Denver, 2001
  Google Scholar
• 13 Perkins R B, Hall J E, Martin K A. Aetiology, previous menstrual function and patterns of neuro-endocrine disturbance as prognostic indicators in hypothalamic amenorrhoea.  Hum Reprod . 2001;  16 2198-2205
  CrossrefPubMedGoogle Scholar
• 14 Laughlin G A, Yen S SC. Hypoleptinemia in women athletes: absence of a diurnal rhythm with amenorrhea.  J Clin Endocrinol Metab . 1997;  82 318-321
  CrossrefPubMedGoogle Scholar
• 15 Miller K K, Parulekar M S, Schoenfeld E. Decreased leptin levels in normal weight women with hypothalamic amenorrhea: the effects of body composition and nutritional intake.  J Clin Endocrinol Metab . 1998;  83 2309-2312
  CrossrefPubMedGoogle Scholar
• 16 Nachtigall L B, Boepple P A, Pralong F P, Crowley Jr F W. Adult-onset idiopathic hypogonadotropic hypogonadism: a treatable form of male infertility.  N Engl J Med . 1997;  336 410-415
  CrossrefPubMedGoogle Scholar
• 17 Sauder S E, Frager M, Case G D, Kelch R P, Marshall J C. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.  J Clin Endocrinol Metab . 1984;  59 941-948
  CrossrefPubMedGoogle Scholar
• 18 Cook C B, Nippoldt T B, Kletter G B, Kelch R P, Marshall J C. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.  J Clin Endocrinol Metab . 1991;  73 1099-1105
  PubMedGoogle Scholar
• 19 Cohen P G. The hypogonadal-obesity cycle: role of aromatase in modulating the testosterone-estradiol shunt: a major factor in the genesis of morbid obesity.  Med Hypotheses . 1999;  52 49-51
  CrossrefPubMedGoogle Scholar
• 20 Zumoff B. Hormonal abnormalities in obesity.  Acta Med Scand Suppl . 1988;  723 153-160
  PubMedGoogle Scholar
• 21 Mayston M J, Harrison L M, Quinton R, Stephens J A, Krams M, Bouloux P M. Mirror movements in X-linked Kallmann's syndrome: a neurophysiological study.  Brain . 1997;  120 1199-1216
  CrossrefPubMedGoogle Scholar
• 22 Oliveira L M, Seminara S B, Beranova M. The importance of autosomal genes in Kallmann's syndrome: genotype-phenotype correlations and neuroendocrine characteristics.  J Clin Endocrinol Metab . 2001;  86 1532-1538
  CrossrefPubMedGoogle Scholar
• 23 Schwanzel-Fukuda M. Origin and migration of luteinizing hormone-releasing hormone neurons in mammals.  Microsc Res Tech . 1999;  44 2-10
  CrossrefPubMedGoogle Scholar
• 24 Hardelin J P. Kallmann syndrome: towards molecular pathogenesis.  Mol Cell Endocrinol . 2001;  179 75-81
  CrossrefPubMedGoogle Scholar
• 25 Hardelin J P, Julliard A K, Moniot B. Anosmin-1 is a regionally restricted component of basement membranes and interstitial matrices during organogenesis: implications for the developmental anomalies of X chromosome-linked Kallmann syndrome.  Dev Dyn . 1999;  215 26-44
  CrossrefPubMedGoogle Scholar
• 26 Robertson A, MacColl G S, Nash J A, Boehm M K, Perkins S J, Bouloux P M. Molecular modelling and experimental studies of mutation and cell-adhesion sites in the fibronectin type III and whey acidic protein domains of human anosmin-1.  Biochem J . 2001;  357 647-659
  CrossrefPubMedGoogle Scholar
• 27 Mason A J, Hayflick J S, Zoeller R T. A deletion truncating the gonadotropin-releasing hormone gene is responsible for hypogonadism in the hpg mouse.  Science . 1986;  234 1366-1371
  PubMedGoogle Scholar
• 28 Beranova M, Oliveira L BM, Bedecarrats G Y. Prevalence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism.  J Clin Endocrinol Metab . 2001;  86 1580-1588
  CrossrefPubMedGoogle Scholar
• 29 Kakar S S, Musgrove L C, Devor D C, Sellers J C, Neill J D. Cloning, sequencing, and expression of human gonadotropin-releasing hormone (GnRH) receptor.  Biochem Biophys Res Commun . 1992;  189 289-295
  CrossrefPubMedGoogle Scholar
• 30 Chi L, Zhou W, Prikhozhan A. Cloning and characterization of the human GnRH receptor.  Mol Cell Endocrinol . 1993;  9 R1-R6
  PubMedGoogle Scholar
• 31 Pitteloud N, Boepple P, DeCruz S, Valkenburgh S B, Crowley Jr F W, Hayes F J. The Fertile Eunuch variant of idiopathic hypogonadotropic hypogonadism: spontaneous reversal associated with a homozygous mutation in the gonadotropin-releasing hormone receptor.  J Clin Endocrinol Metab . 2001;  86 2470-2475
  CrossrefPubMedGoogle Scholar
• 32 Pralong F P, Gomez F, Castillo E. Complete hypogonadotropic hypogonadism associated with a novel inactivating mutation of the gonadotropin-releasing hormone receptor.  J Clin Endocrinol Metab . 1999;  84 3811-3816
  CrossrefPubMedGoogle Scholar
• 33 Kottler M L, Chauvin S, Lahlou N. A new compound heterozygous mutation of the gonadotropin-releasing hormone receptor (L314X, Q106R) in a woman with complete hypogonadotropic hypogonadism: chronic estrogen administration amplifies the gonadotropin defect.  J Clin Endocrinol Metab . 2000;  85 3002-3008
  CrossrefPubMedGoogle Scholar
• 34 Soderlund D, Canto P, de la Chesnaye E, Ulloa-Aguirre A, Mendez J P. A novel homozygous mutation in the second transmembrane domain of the gonadotropin releasing hormone receptor gene.  Clin Endocrinol . 2001;  54 493-498
  CrossrefPubMedGoogle Scholar
• 35 Costa E MF, Bedecarrats G Y, Mendonca B B, Arnhold I JP, Kaiser U B, Latronico A C. Two novel mutations in the gonadotropin-releasing hormone receptor gene in Brazilian patients with hypogonadotropic hypogonadism and normal olfaction.  J Clin Endocrinol Metab . 2001;  86 2680-2686
  CrossrefPubMedGoogle Scholar
• 36 De Roux N, Young J, Brailly-Tabard S. The same molecular defects of the gonadotropin-releasing hormone receptor determine a variable degree of hypogonadism in affected kindred. J Clin Endocrinol Metab .  1999;  84 567-572
  PubMedGoogle Scholar
• 37 Weiss J, Axelrod L, Whitcomb R W, Harris P E, Crowley W F, Jameson J L. Hypogonadism caused by a single amino acid substitution in the beta subunit of luteinizing hormone.  N Engl J Med . 1992;  326 179-183
  PubMedGoogle Scholar
• 38 Matthews C H, Borgato S, Beck-Peccoz P. Primary amenorrhoea and infertility due to a mutation in the beta-subunit of follicle-stimulating hormone.  Nat Genet . 1993;  5 83-86
  CrossrefPubMedGoogle Scholar
• 39 Layman L C. Mutations in the follicle-stimulating hormone-beta (FSH beta) and FSH receptor genes in mice and humans.  Semin Reprod Med . 2000;  18 5-10
  Article in Thieme ConnectPubMedGoogle Scholar
• 40 Hermesz E, Mackem S, Mahon K A. Rpx: a novel anterior-restricted homeobox gene progressively activated in the prechordal plate, anterior neural plate and Rathke's pouch of the mouse embryo.  Development . 1996;  122 41-52
  PubMedGoogle Scholar
• 41 Dattani M T, Robinson I C. The molecular basis for developmental disorders of the pituitary gland in man.  Clin Genet . 2000;  57 337-346
  CrossrefPubMedGoogle Scholar
• 42 Dattani M T, Martinez-Barbera J P, Thomas P Q. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse.  Nat Genet . 1998;  19 125-133
  CrossrefPubMedGoogle Scholar
• 43 Thomas P Q, Dattani M T, Brickman J M. Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia.  Hum Mol Genet . 2001;  10 39-45
  CrossrefPubMedGoogle Scholar
• 44 Bridwell J L, Price J R, Parker G E, McCutchan Schiller A, Sloop K W, Rhodes S J. Role of the LIM domains in DNA recognition by the Lhx3 neuroendocrine transcription factor.  Gene . 2001;  277 239-250
  CrossrefPubMedGoogle Scholar
• 45 Sheng H Z, Zhadanov A B, Mosinger Jr B. Specification of pituitary cell lineages by the LIM homeobox gene Lhx3.  Science . 1996;  272 1004-1007
  PubMedGoogle Scholar
• 46 Netchine I, Sobrier M L, Krude H. Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency.  Nat Genet . 2000;  25 182-186
  PubMedGoogle Scholar
• 47 Sloop K W, Dwyer C J, Rhodes S J. An isoform-specific inhibitory domain regulates the LHX3 LIM homeodomain factor holoprotein and the production of a functional alternate translation form.  J Biol Chem . 2001;  276 36311-36319
  CrossrefPubMedGoogle Scholar
• 48 Sornson M W, Wu W, Dasen J S. Pituitary lineage determination by the prophet of Pit-1 homeodomain factor defective in Ames dwarfism.  Nature . 1996;  384 327-333
  CrossrefPubMedGoogle Scholar
• 49 Deladoey J, Fluck C, Buyukgebiz A. "Hot spot" in the PROP1 gene responsible for combined pituitary hormone deficiency.  J Clin Endocrinol Metab . 1999;  84 1645-1650
  CrossrefPubMedGoogle Scholar
• 50 Wu W, Cogan J D, Pfaffle R W. Mutations in PROP1 cause familial combined pituitary hormone deficiency.  Nat Genet . 1998;  18 147-149
  CrossrefPubMedGoogle Scholar
• 51 Fluck C, Deladoey J, Rutishauser K. Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg → Cys at codon 120 (R120C).  J Clin Endocrinol Metab . 1998;  83 3727-3734
  CrossrefPubMedGoogle Scholar
• 52 Parker K L, Schimmer B P. Steroidogenic factor 1: a key determinant of endocrine development and function.  Endocr Rev . 1997;  18 361-377
  CrossrefPubMedGoogle Scholar
• 53 Bakke M, Zhao L, Parker K L. Approaches to define the role of SF-1 at different levels of the hypothalamic-pituitary-steroidogenic organ axis.  Mol Cell Endocrinol . 2001;  179 33-37
  CrossrefPubMedGoogle Scholar
• 54 Achermann J C, Ito M, Ito M, Hindmarsh P C, Jameson J L. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans.  Nat Genet . 1999;  22 125-126
  CrossrefPubMedGoogle Scholar
• 55 Muscatelli F, Strom T M, Walker A P. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism.  Nature . 1994;  372 672-676
  CrossrefPubMedGoogle Scholar
• 56 Zanaria E, Muscatelli F, Bardoni B. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita.  Nature . 1994;  372 635-641
  CrossrefPubMedGoogle Scholar
• 57 Zhang Y H, Guo W, Wagner R L, Huang B L. DAX1 mutations provide insight into structure-function relationships in steroidogenic tissue development.  Am J Hum Genet . 1998;  62 855-864
  CrossrefPubMedGoogle Scholar
• 58 Achermann J C, Jameson J L. Advances in the molecular genetics of hypogonadotropic hypogonadism.  J Pediatr Endocrinol Metab . 2001;  14 3-15
  PubMedGoogle Scholar
• 59 Reutens A T, Achermann J C, Ito M. Clinical and functional effects of mutations in the DAX-1 gene in patients with adrenal hypoplasia congenita.  J Clin Endocrinol Metab . 1999;  84 504-511
  CrossrefPubMedGoogle Scholar
• 60 Ito M, Yu R, Jameson J L. DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita.  Mol Cell Endocrinol . 1997;  17 1476-1483
  PubMedGoogle Scholar
• 61 Achermann J C, Weiss J, Lee E J, Jameson J L. Inherited disorders of the gonadotropin hormones.  Mol Cell Endocrinol . 2001;  179 89-96
  CrossrefPubMedGoogle Scholar
• 62 Takahashi T, Shoji Y, Shoji Y, Haraguchi N, Takahashi I, Takada G. Active hypothalamic-pituitary-gonadal axis in an infant with X-linked adrenal hypoplasia congenital.  J Pediatr . 1997;  130 485-488
  PubMedGoogle Scholar
• 63 Habiby R L, Boepple P, Nachtigall L, Sluss P M, Crowley Jr F W, Jameson J L. Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypothalmic and pituitary defects in gonadotropin production.  J Clin Invest . 1996;  98 1055-1062
  PubMedGoogle Scholar
• 64 Seminara S B, Achermann J C, Genel M, Jameson J L, Crowley Jr F W. X-linked adrenal hypoplasia congenita: a mutation in DAX1 expands the phenotypic spectrum in males and females.  J Clin Endocrinol Metab . 1999;  84 4501-4509
  CrossrefPubMedGoogle Scholar
• 65 Chehab F F, Lim M E, Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin.  Nat Genet . 1996;  12 318-320
  CrossrefPubMedGoogle Scholar
• 66 Montague C T, Farooqi I S, Whitehead J P. Congenital leptin deficiency is associated with severe early-onset obesity in humans.  Nature . 1997;  387 903-908
  CrossrefPubMedGoogle Scholar
• 67 Strobel A, Issad T, Camoin L, Ozata M, Strosberg A D. A leptin missense mutation associated with hypogonadism and morbid obesity.  Nat Genet . 1998;  18 213-215
  CrossrefPubMedGoogle Scholar
• 68 Wauters M, Considine R V, Van Gaal F L. Human leptin: from an adipocyte hormone to an endocrine mediator.  Eur J Endocrinol . 2000;  143 293-311
  CrossrefPubMedGoogle Scholar
• 69 Clement K, Vaisse C, Lahlou N. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction.  Nature . 1998;  392 398-401
  CrossrefPubMedGoogle Scholar
• 70 Jackson R S, Creemers J W, Ohagi S. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene.  Nat Genet . 1997;  16 303-306
  PubMedGoogle Scholar
• 71 Hayes F J, Seminara S B, Crowley Jr F W. Hypogonadotropic hypogonadism.  Endocrinol Metab Clin North Am . 1998;  27 739-763
  CrossrefPubMedGoogle Scholar
• 72 Buchter D, Behre H M, Kliesch S, Nieschlag E. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases.  Eur J Endocrinol . 1998;  139 298-303
  CrossrefPubMedGoogle Scholar
• 73 Liu P Y, Turner L, Rushford D. Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men.  Hum Reprod . 1999;  14 1540-1545
  CrossrefPubMedGoogle Scholar
• 74 Jones T H, Darne J F. Self-administered subcutaneous human menopausal gonadotrophin for the stimulation of testicular growth and the initiation of spermatogenesis in hypogonadotrophic hypogonadism.  Clin Endocrinol (Oxf) . 1993;  38 203-208
  CrossrefPubMedGoogle Scholar
• 75 Schopohl J. Pulsatile gonadotrophin releasing hormone versus gonadotrophin treatment of hypothalamic hypogonadism in males.  Hum Reprod . 1993;  8 (suppl 2) 175-179
  PubMedGoogle Scholar
• 76 Kirk J M, Savage M O, Grant D B, Bouloux P M, Besser G M. Gonadal function and response to human chorionic and menopausal gonadotrophin therapy in male patients with idiopathic hypogonadotrophic hypogonadism.  Clin Endocrinol (Oxf) . 1994;  41 57-63
  PubMedGoogle Scholar
• 77 Ginsburg J, Hardiman P. Ovulation induction with human menopausal gonadotropins: a changing scene.  Gynecol Endocrinol . 1991;  5 57-78
  PubMedGoogle Scholar
• 78 Seminara S B, Beranova M, Oliveira L M, Martin K A, Crowley Jr F W, Hall J E. Successful use of pulsatile gonadotropin-releasing hormone (GnRH) for ovulation induction and pregnancy in a patient with GnRH receptor mutations.  J Clin Endocrinol Metab . 2000;  85 556-562
  CrossrefPubMedGoogle Scholar
• 79 Martin K A, Hall J E, Adams J M, Crowley Jr F W. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea.  J Clin Endocrinol Metab . 1993;  77 125-129
  CrossrefPubMedGoogle Scholar